- Marinus Pharmaceuticals (NASDAQ:MRNS) initiated with Buy rating and $33 (443% upside) price target at H.C. Wainwright. Shares up 4% premarket.
- Arsanis (NASDAQ:ASNS) initiated with Overweight rating with a $26 (111% upside) price target at Cantor Fitzgerald.
- PolarityTE (COOL) initiated with Overweight rating and $70 (245% upside) price target at Cantor. Shares up 17% premarket.
- Adverum Biotechnologies (NASDAQ:ADVM) resumed with Overweight rating and $12 (85% upside) price target at Piper Jaffray. Shares up 5% premarket.
- Henry Schein (NASDAQ:HSIC) resumed with Neutral rating and $77 (13% upside) price target at JPMorgan. Shares down 1% premarket.
- Atara Biotherapeutics (NASDAQ:ATRA) downgraded to Sell at Citigroup. Shares down 6% premarket.
Premarket analyst action - healthcare
Recommended For You
More Trending News
About MRNS Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
MRNS | - | - |
Marinus Pharmaceuticals, Inc. |